首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1561656

2024-2032 年按類型（A 型毒素、B 型毒素）、應用（治療、美容）、最終用戶（醫院和診所、皮膚科診所、水療中心和美容中心）和地區分類的肉毒桿菌毒素市場報告

Botulinum Toxin Market Report by Type (Toxin Type A, Toxin Type B), Application (Therapeutics, Aesthetics), End User (Hospitals and Clinics, Dermatology Clinics, Spas and Cosmetic Centers), and Region 2024-2032

出版日期: 2024年09月10日 | 出版商:

IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年，全球肉毒桿菌毒素IMARC Group規模達到58億美元。

肉毒桿菌毒素是由肉毒桿菌產生的神經毒素，肉毒桿菌是一種厭氧、革蘭氏陽性、產芽孢桿，常見於植物、土壤、水和動物腸道。它在各種醫療狀況的管理中發揮著重要作用。這些病症包括斜視和局部肌張力失調、顏面肌痙攣、頭痛、唾液分泌過多、多汗症和痙攣性運動障礙。此外，它也用於治療對現有藥物治療有部分反應的各種慢性疾病。如今，它也用於暫時減少皺眉紋、皺紋以及臉部、下巴、頸部和胸部皺紋的美容目的。

肉毒桿菌毒素市場趨勢：

慢性和急性疾病的盛行率和診斷率顯著上升是推動市場成長的關鍵因素之一。肉毒桿菌毒素廣泛應用於治療皮膚病，例如平滑肌過度活躍、腺體活動異常和多汗症。此外，個人美容意識的不斷增強，以及他們接受重建和整容手術的意願，正在促進市場的成長。此外，美容旅遊的興起，加上社交媒體影響力的增強、城市化的快速發展以及人均收入的不斷膨脹，正在對市場產生積極的影響。除此之外，隨著年齡的成長，皮膚變得更容易出現皺紋和下垂，不斷成長的老年人口以及保持年輕健康皮膚的願望正在推動市場成長。此外，透過組合不同血清型來開發新的強效毒素可以減少總單位和總抗原劑量，並提高有效性和作用持續時間。這些進步預計將為市場創造積極的前景。

本報告回答的關鍵問題

2023年全球肉毒桿菌毒素市場規模有多大？ 2024-2032年全球肉毒桿菌毒素市場的預期成長率是多少？
COVID-19 對全球肉毒桿菌毒素市場有何影響？
推動全球肉毒桿菌毒素市場的關鍵因素是什麼？
全球肉毒桿菌市場按類型分類是怎樣的？
根據應用，全球肉毒桿菌市場的詳細情形如何？
基於最終用戶的全球肉毒毒素市場的詳細情形如何？
全球肉毒桿菌毒素市場的重點區域有哪些？
誰是全球肉毒桿菌毒素市場的主要參與者/公司？

Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum, which is an anaerobic, gram-positive, spore-forming rod commonly found in plants, soil, water, and intestinal tracts of animals. It plays a significant role in the management of a wide variety of medical conditions. These conditions include strabismus and focal dystonia, hemifacial spasm, headaches, hypersalivation, hyperhidrosis, and spastic movement disorders. Moreover, it is utilized in the treatment of various chronic diseases that respond partially to available medical treatments. Nowadays, it is also used for the cosmetic purpose of temporarily reducing frown lines, creases, and wrinkles on the face, chin, neck, and chest.

Botulinum Toxin Market Trends:

A significant rise in the prevalence and diagnosis of chronic and acute diseases represents one of the key factors bolstering the market growth. Botulinum toxin finds extensive applications in the treatment of dermatological conditions, such as overactive smooth muscles, abnormal activity of glands, and hyperhidrosis. Moreover, the rising beauty consciousness among individuals, along with their willingness to undergo reconstructive and cosmetic surgeries, is contributing to market growth. In addition, the emerging trend of cosmetic tourism, in confluence with the increasing influence of social media, rapid urbanization, and inflating per capita income, is influencing the market positively. Apart from this, as the skin becomes more susceptible to wrinkles and sagging with age, the growing geriatric population and the desire to retain young and healthy skin are bolstering the market growth. Furthermore, the development of new potent toxins by combining different serotypes can reduce the total units and overall antigenic dose and improve effectiveness and duration of effect. These advancements are projected to create a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global botulinum toxin market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, application and end user.

Breakup by Type:

Toxin Type A
Toxin Type B

Breakup by Application:

Therapeutics
Aesthetics

Breakup by End User:

Hospitals and Clinics
Dermatology Clinics
Spas and Cosmetic Centers

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Eisai Co. Ltd, Evolus Inc, Galderma SA, HUGEL Inc., Ipsen Group, Medytox Inc., Merz Pharma GmbH & Co. KGaA, Metabiologics Inc. and Revance Therapeutics Inc.

Key Questions Answered in This Report

1. What was the size of the global botulinum toxin market in 2023?
2. What is the expected growth rate of the global botulinum toxin market during 2024-2032?
3. What has been the impact of COVID-19 on the global botulinum toxin market?
4. What are the key factors driving the global botulinum toxin market?
5. What is the breakup of the global botulinum toxin market based on type?
6. What is the breakup of the global botulinum toxin market based on the application?
7. What is the breakup of the global botulinum toxin market based on the end user?
8. What are the key regions in the global botulinum toxin market?
9. Who are the key players/companies in the global botulinum toxin market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Botulinum Toxin Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Type

6.1 Toxin Type A
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Toxin Type B
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Application

7.1 Therapeutics
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Aesthetics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by End User

8.1 Hospitals and Clinics
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Dermatology Clinics
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Spas and Cosmetic Centers
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Region

9.1 North America
- 9.1.1 United States
  - 9.1.1.1 Market Trends
  - 9.1.1.2 Market Forecast
- 9.1.2 Canada
  - 9.1.2.1 Market Trends
  - 9.1.2.2 Market Forecast
9.2 Asia-Pacific
- 9.2.1 China
  - 9.2.1.1 Market Trends
  - 9.2.1.2 Market Forecast
- 9.2.2 Japan
  - 9.2.2.1 Market Trends
  - 9.2.2.2 Market Forecast
- 9.2.3 India
  - 9.2.3.1 Market Trends
  - 9.2.3.2 Market Forecast
- 9.2.4 South Korea
  - 9.2.4.1 Market Trends
  - 9.2.4.2 Market Forecast
- 9.2.5 Australia
  - 9.2.5.1 Market Trends
  - 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
  - 9.2.6.1 Market Trends
  - 9.2.6.2 Market Forecast
- 9.2.7 Others
  - 9.2.7.1 Market Trends
  - 9.2.7.2 Market Forecast
9.3 Europe
- 9.3.1 Germany
  - 9.3.1.1 Market Trends
  - 9.3.1.2 Market Forecast
- 9.3.2 France
  - 9.3.2.1 Market Trends
  - 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
  - 9.3.3.1 Market Trends
  - 9.3.3.2 Market Forecast
- 9.3.4 Italy
  - 9.3.4.1 Market Trends
  - 9.3.4.2 Market Forecast
- 9.3.5 Spain
  - 9.3.5.1 Market Trends
  - 9.3.5.2 Market Forecast
- 9.3.6 Russia
  - 9.3.6.1 Market Trends
  - 9.3.6.2 Market Forecast
- 9.3.7 Others
  - 9.3.7.1 Market Trends
  - 9.3.7.2 Market Forecast
9.4 Latin America
- 9.4.1 Brazil
  - 9.4.1.1 Market Trends
  - 9.4.1.2 Market Forecast
- 9.4.2 Mexico
  - 9.4.2.1 Market Trends
  - 9.4.2.2 Market Forecast
- 9.4.3 Others
  - 9.4.3.1 Market Trends
  - 9.4.3.2 Market Forecast
9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast

10 SWOT Analysis

10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
- 14.3.1 AbbVie Inc.
  - 14.3.1.1 Company Overview
  - 14.3.1.2 Product Portfolio
  - 14.3.1.3 Financials
  - 14.3.1.4 SWOT Analysis
- 14.3.2 Eisai Co. Ltd
  - 14.3.2.1 Company Overview
  - 14.3.2.2 Product Portfolio
  - 14.3.2.3 Financials
  - 14.3.2.4 SWOT Analysis
- 14.3.3 Evolus Inc
  - 14.3.3.1 Company Overview
  - 14.3.3.2 Product Portfolio
  - 14.3.3.3 Financials
- 14.3.4 Galderma SA
  - 14.3.4.1 Company Overview
  - 14.3.4.2 Product Portfolio
  - 14.3.4.3 SWOT Analysis
- 14.3.5 HUGEL Inc.
  - 14.3.5.1 Company Overview
  - 14.3.5.2 Product Portfolio
  - 14.3.5.3 Financials
- 14.3.6 Ipsen Group
  - 14.3.6.1 Company Overview
  - 14.3.6.2 Product Portfolio
- 14.3.7 Medytox Inc.
  - 14.3.7.1 Company Overview
  - 14.3.7.2 Product Portfolio
  - 14.3.7.3 Financials
- 14.3.8 Merz Pharma GmbH & Co. KGaA
  - 14.3.8.1 Company Overview
  - 14.3.8.2 Product Portfolio
- 14.3.9 Metabiologics Inc.
  - 14.3.9.1 Company Overview
  - 14.3.9.2 Product Portfolio
- 14.3.10 Revance Therapeutics Inc.
  - 14.3.10.1 Company Overview
  - 14.3.10.2 Product Portfolio
  - 14.3.10.3 Financials

簡介目錄圖表

List of Figures

Figure 1: Global: Botulinum Toxin Market: Major Drivers and Challenges
Figure 2: Global: Botulinum Toxin Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Botulinum Toxin Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Botulinum Toxin Market: Breakup by Type (in %), 2023
Figure 5: Global: Botulinum Toxin Market: Breakup by Application (in %), 2023
Figure 6: Global: Botulinum Toxin Market: Breakup by End User (in %), 2023
Figure 7: Global: Botulinum Toxin Market: Breakup by Region (in %), 2023
Figure 8: Global: Botulinum Toxin (Toxin Type A) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Botulinum Toxin (Toxin Type A) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Botulinum Toxin (Toxin Type B) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Botulinum Toxin (Toxin Type B) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Botulinum Toxin (Therapeutics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Botulinum Toxin (Therapeutics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Botulinum Toxin (Aesthetics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Botulinum Toxin (Aesthetics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Botulinum Toxin (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Botulinum Toxin (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Botulinum Toxin (Dermatology Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Botulinum Toxin (Dermatology Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Botulinum Toxin (Spas and Cosmetic Centers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Botulinum Toxin (Spas and Cosmetic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: North America: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: North America: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: United States: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: United States: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Canada: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Canada: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Asia-Pacific: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Asia-Pacific: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: China: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: China: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Japan: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Japan: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: India: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: India: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: South Korea: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: South Korea: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Australia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Australia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Indonesia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Indonesia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Europe: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Europe: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Germany: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Germany: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: France: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: France: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: United Kingdom: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: United Kingdom: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Italy: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Italy: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Spain: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Spain: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Russia: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Russia: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Latin America: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Latin America: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Brazil: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Brazil: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Mexico: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Mexico: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Middle East and Africa: Botulinum Toxin Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Middle East and Africa: Botulinum Toxin Market: Breakup by Country (in %), 2023
Figure 70: Middle East and Africa: Botulinum Toxin Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Global: Botulinum Toxin Industry: SWOT Analysis
Figure 72: Global: Botulinum Toxin Industry: Value Chain Analysis
Figure 73: Global: Botulinum Toxin Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Botulinum Toxin Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Botulinum Toxin Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 3: Global: Botulinum Toxin Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Botulinum Toxin Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Botulinum Toxin Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Botulinum Toxin Market: Competitive Structure
Table 7: Global: Botulinum Toxin Market: Key Players

02-2729-4219

+886-2-2729-4219